A synbiotic mixture of selected oligosaccharides and bifidobacteria assists murine gut microbiota restoration following antibiotic challenge.
Journal
Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147
Informations de publication
Date de publication:
02 08 2023
02 08 2023
Historique:
received:
10
06
2022
accepted:
09
06
2023
medline:
3
8
2023
pubmed:
2
8
2023
entrez:
1
8
2023
Statut:
epublish
Résumé
Typically, animal models studying gastrointestinal microbiotas compromised in early life have employed either germ-free animals or mice treated with a cocktail of antibiotics. Such studies intend to mimic scenarios of infants born by caesarean section and/or subjected to antibiotic treatment. However, the antibiotics used in these studies are rarely prescribed to infants. Therefore, an early life model was developed in which the murine gastrointestinal microbiota was severely disrupted by clindamycin treatment. In this mouse model, we investigated the extent supplementation with a synbiotic mixture of prebiotics, being scGOS/lcFOS with the human milk oligosaccharide 2'-Fucosyllactose (2'-FL), in combination with or without single strain or mix of "infant type" bifidobacteria, can rescue an antibiotic-compromised microbiota. Shotgun metagenomic sequencing showed that the microbiota was severely disrupted by the clindamycin challenge. No recovery was observed 3 weeks post-challenge in the scGOS/lcFOS/2'FL group, while the group that received the synbiotic treatment of scGOS/lcFOS/2'-FL with Bifidobacterium breve NRBB01 showed partial recovery. Strikingly in the scGOS/lcFOS/2'-FL group receiving the mixture of bifidobacteria resulted in a recovery of the microbiota disruption. Histological analyses showed that the clindamycin-treated animals at the end of the experiment still suffered from mild oedema and villi/colonic crypt irregularities which was ameliorated by the synbiotic intervention. Our study demonstrates that supplementation of synbiotic mixture of scGOS/lcFOS/2'-FL in combination with a specific mix of infant-type bifidobacterial strains is able to partially revive an antibiotic-perturbed gastrointestinal microbiota. Video Abstract.
Sections du résumé
BACKGROUND
Typically, animal models studying gastrointestinal microbiotas compromised in early life have employed either germ-free animals or mice treated with a cocktail of antibiotics. Such studies intend to mimic scenarios of infants born by caesarean section and/or subjected to antibiotic treatment. However, the antibiotics used in these studies are rarely prescribed to infants. Therefore, an early life model was developed in which the murine gastrointestinal microbiota was severely disrupted by clindamycin treatment.
RESULTS
In this mouse model, we investigated the extent supplementation with a synbiotic mixture of prebiotics, being scGOS/lcFOS with the human milk oligosaccharide 2'-Fucosyllactose (2'-FL), in combination with or without single strain or mix of "infant type" bifidobacteria, can rescue an antibiotic-compromised microbiota. Shotgun metagenomic sequencing showed that the microbiota was severely disrupted by the clindamycin challenge. No recovery was observed 3 weeks post-challenge in the scGOS/lcFOS/2'FL group, while the group that received the synbiotic treatment of scGOS/lcFOS/2'-FL with Bifidobacterium breve NRBB01 showed partial recovery. Strikingly in the scGOS/lcFOS/2'-FL group receiving the mixture of bifidobacteria resulted in a recovery of the microbiota disruption. Histological analyses showed that the clindamycin-treated animals at the end of the experiment still suffered from mild oedema and villi/colonic crypt irregularities which was ameliorated by the synbiotic intervention.
CONCLUSION
Our study demonstrates that supplementation of synbiotic mixture of scGOS/lcFOS/2'-FL in combination with a specific mix of infant-type bifidobacterial strains is able to partially revive an antibiotic-perturbed gastrointestinal microbiota. Video Abstract.
Identifiants
pubmed: 37528457
doi: 10.1186/s40168-023-01595-x
pii: 10.1186/s40168-023-01595-x
pmc: PMC10394833
doi:
Substances chimiques
Anti-Bacterial Agents
0
Clindamycin
3U02EL437C
Oligosaccharides
0
Types de publication
Video-Audio Media
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
168Subventions
Organisme : Science Foundation Ireland
ID : SFI/12/RC/2273_P2
Pays : Ireland
Informations de copyright
© 2023. The Author(s).
Références
Pediatr Allergy Immunol. 2006 Mar;17(2):134-40
pubmed: 16618363
Front Microbiol. 2018 May 08;9:888
pubmed: 29867801
Korean J Food Sci Anim Resour. 2017;37(3):368-375
pubmed: 28747822
Bull World Health Organ. 2017 Jan 01;95(1):49-61
pubmed: 28053364
Curr Opin Pediatr. 2016 Apr;28(2):141-9
pubmed: 26886785
Infect Immun. 2011 Apr;79(4):1536-45
pubmed: 21321077
Appl Microbiol Biotechnol. 2014 Jul;98(13):6051-60
pubmed: 24687755
Sci Rep. 2018 Jul 13;8(1):10633
pubmed: 30006593
Microbiome. 2019 Sep 14;7(1):132
pubmed: 31521198
Clin Exp Med. 2015 Feb;15(1):107-20
pubmed: 24414342
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):681-687
pubmed: 27035371
J Infect Dis. 1973 Oct;128(4):569-71
pubmed: 4743549
Microorganisms. 2020 Aug 28;8(9):
pubmed: 32872165
Jpn J Antibiot. 1977 Jan;30(1):30-5
pubmed: 839641
Microbiology (Reading). 2012 Nov;158(Pt 11):2826-2834
pubmed: 22902730
Int J Food Microbiol. 2011 Sep 1;149(1):73-80
pubmed: 21450362
J Pediatr Gastroenterol Nutr. 2016 Oct;63(4):e43-53
pubmed: 27472478
Sci Rep. 2017 Aug 17;7(1):8527
pubmed: 28819121
Adv Nutr. 2012 May 01;3(3):422S-9S
pubmed: 22585921
FEMS Microbiol Lett. 2005 Feb 1;243(1):141-7
pubmed: 15668012
Cell Host Microbe. 2015 May 13;17(5):690-703
pubmed: 25974306
J Nutr. 2008 Jun;138(6):1141-7
pubmed: 18492847
Sci Rep. 2020 Sep 25;10(1):15792
pubmed: 32978424
J Exp Med. 1968 Jul 1;128(1):97-110
pubmed: 5662019
PLoS One. 2016 Apr 25;11(4):e0154012
pubmed: 27111772
Sci Rep. 2019 Feb 5;9(1):1437
pubmed: 30723224
Microbiol Mol Biol Rev. 2017 Nov 8;81(4):
pubmed: 29118049
Infect Control Hosp Epidemiol. 1994 Mar;15(3):156-62
pubmed: 8207172
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Clin Nutr. 2009 Apr;28(2):156-61
pubmed: 19231042
ACS Synth Biol. 2021 Mar 19;10(3):447-458
pubmed: 33687208
Appl Environ Microbiol. 2007 Dec;73(24):7858-66
pubmed: 17965208
Methods Mol Biol. 2012;842:1-26
pubmed: 22259127
Cell. 2018 Sep 6;174(6):1406-1423.e16
pubmed: 30193113
Biosci Microbiota Food Health. 2018;37(4):79-85
pubmed: 30370191
Behav Neurosci. 2005 Feb;119(1):293-301
pubmed: 15727533
Allergy. 2009 Mar;64(3):484-7
pubmed: 18507650
EMBO Rep. 2012 May 01;13(5):440-7
pubmed: 22422004
Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):687-701
pubmed: 32826966
Br J Nutr. 2016 Jul;116(2):294-9
pubmed: 27212112
J Nutr. 1997 May;127(5 Suppl):838S-841S
pubmed: 9164249
J Agric Food Chem. 2021 Jan 13;69(1):170-182
pubmed: 33382612
Ann Intern Med. 2012 Dec 18;157(12):878-88
pubmed: 23362517
J Clin Med. 2021 Jan 25;10(3):
pubmed: 33504109
J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):102-106
pubmed: 28644357
N Engl J Med. 2007 Jul 26;357(4):380-90
pubmed: 17652653
BMC Microbiol. 2021 Jun 25;21(1):191
pubmed: 34172012
Microorganisms. 2019 Feb 14;7(2):
pubmed: 30769786
Front Microbiol. 2020 Jun 18;11:1349
pubmed: 32625197
Gut Microbes. 2016;7(2):101-14
pubmed: 26963277
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Microbiome. 2018 Oct 16;6(1):182
pubmed: 30326954
Sci Transl Med. 2016 Jun 15;8(343):343ra81
pubmed: 27306663
Sci Rep. 2017 Aug 21;7(1):8327
pubmed: 28827640
Infect Immun. 2009 Sep;77(9):3661-9
pubmed: 19564382
Front Microbiol. 2016 Apr 29;7:624
pubmed: 27199952
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):491-502
pubmed: 28611480
Front Microbiol. 2021 Mar 23;12:636822
pubmed: 33833740
J Nutr. 2007 Nov;137(11):2420-4
pubmed: 17951479
Infect Immun. 2012 Jan;80(1):62-73
pubmed: 22006564
Methods Mol Biol. 2021;2278:13-19
pubmed: 33649944
Nat Commun. 2021 Jan 26;12(1):443
pubmed: 33500411
Cell. 2021 Jul 22;184(15):3884-3898.e11
pubmed: 34143954
Gut. 2008 Jul;57(7):1025-6
pubmed: 18559395
Regul Toxicol Pharmacol. 2003 Dec;38(3):317-25
pubmed: 14623482
ISME J. 2020 Feb;14(2):635-648
pubmed: 31740752
PLoS One. 2014 Apr 17;9(4):e94875
pubmed: 24743599
Pediatrics. 2006 Aug;118(2):511-21
pubmed: 16882802
Nurs Res. 2016 Jan-Feb;65(1):76-88
pubmed: 26657483
Sci Rep. 2018 Mar 23;8(1):5098
pubmed: 29572473
Appl Microbiol Biotechnol. 2020 Jun;104(11):4995-5009
pubmed: 32303819
Sci Transl Med. 2015 Sep 30;7(307):307ra152
pubmed: 26424567
Histochemie. 1970;21(2):97-116
pubmed: 4907154
Front Cell Infect Microbiol. 2018 Oct 23;8:372
pubmed: 30406046
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3047-52
pubmed: 21282636